Guidelines for management of patients with neuromuscular disorders during covid-19 pandemic

Abstract

The coronavirus-19 disease (COVID-19) pandemic has resulted in reorganization of healthcare settings with potential impact in the delivery of clinical care to patients with neuromuscular disorders. These patients may harbour an increased risk of severe complications related to COVID-19. Several risk factors are identified such as respiratory weakness, cardiac involvement, immunosuppression and presence of comorbidities, among others. Therapeutic decisions must be considered in the best interest of the patients, and the society, with no denial of the best treatment possible. Clinical recommendations, based on expertise opinion, are presented for clinical care of patients with neuromuscular disorders.